MYGN - Myriad Genetics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
6/29/2019
6/29/2018
6/29/2017
6/29/2016
Total Revenue
835,100
851,100
772,600
771,400
753,800
Cost of Revenue
201,000
201,000
177,200
171,200
157,300
Gross Profit
634,100
650,100
595,400
600,200
596,500
Operating Expenses
Research Development
86,100
85,900
70,800
74,400
70,600
Selling General and Administrative
561,100
555,500
467,100
476,400
359,100
Total Operating Expenses
647,200
641,400
537,900
550,800
429,700
Operating Income or Loss
-13,100
8,700
57,500
49,400
166,800
Interest Expense
12,700
12,000
3,200
6,000
-
Total Other Income/Expenses Net
-700
100
60,800
-1,700
1,200
Income Before Tax
-23,100
0
116,900
42,900
168,900
Income Tax Expense
-7,700
-4,400
-13,900
21,300
43,600
Income from Continuing Operations
-15,400
4,400
130,800
21,600
125,300
Net Income
-15,300
4,600
131,000
21,800
125,300
Net Income available to common shareholders
-15,300
4,600
131,000
21,800
125,300
Reported EPS
Basic
-
0.06
1.89
0.32
1.79
Diluted
-
0.06
1.82
0.32
1.71
Weighted average shares outstanding
Basic
-
73,500
69,400
68,300
70,000
Diluted
-
76,000
72,000
68,800
73,400
EBITDA
-
85,000
174,500
97,200
193,500